RxDoctor Payments Data

Darlene Proctor

Family · Petersburg, VANPI 1659506954

Payments from drug & device makers

$1,396in general payments, 2019–2025

Across 77 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$317
  • Lilly USA, LLC$114
  • Sanofi$105
  • GSK$98
  • Bristol Myers Squibb$81
  • Amgen$78
  • plus $603 from 17 others

What the payments were for

  • Food & beverage$1,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,396 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$34,862
Medicare patients
95
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin37$41,432
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$36,622
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$24,137
LinzessLinaclotide17$23,758
MeloxicamMeloxicam, Submicronized14$8,785
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,060
SymbicortBudesonide/Formoterol Fumarate11$4,781
Albuterol Sulfate HfaAlbuterol Sulfate83$4,123
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,983
Atorvastatin Calcium126$1,083
Fluticasone Propionate27$953
Trazodone Hcl68$747
Levothyroxine Sodium56$691
Metoprolol Succinate56$640
Amlodipine Besylate125$590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$98$36,62229 claims
AstraZenecaBreztri Aerosphere, Symbicort$31$28,91832 claims
AbbVieLinzess$317$23,75817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,332 family providers in Virginia.

Other family in Petersburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →